• CONCLUSION: The "landing strip" technique appears to be an effective way to assist with iStent implantation.
medications than phacoemulsification alone [1] [2] .
The standard surgical technique for iStent insertion can be performed before or after phacoemulsification based on the preference of the surgeon. For optimal viewing, the head of the patient is rotated 35° away from the surgeon while the surgical microscope oculars are rotated 35° toward the surgeon. An ophthalmic viscoelastic device is inserted into the anterior chamber to widen the nasal angle. The iStent applicator is brought across the anterior chamber toward the nasal angle under direct gonioscopic view. The stent is released from the applicator, punctures the TM, and is inserted into Schlemm's canal [3] .
With dimensions of 1 mm in length and 0.3 mm in height, it can be challenging to successfully place an iStent under direct gonioscopic view. Intraoperative challenges include poor angle visualization and stent malpositioning [1, 4] . The purpose of the present study is to describe a novel technique of creating a landing strip within the TM to assist with iStent implantation. Statistical Analysis Medical records were reviewed and data was analyzed using SAS Analytics Pro software, version
SUBJECTS AND METHODS

Our
(SAS Institute Inc, Cary, NC, USA). The t-test was used
to compare the data before and after operation. P<0.05 was considered statistical significance.
RESULTS
Stent implantation via this technique was performed in 34 eyes
of 30 patients. A summary of patient demographics is shown in Table 1 . Pre-operative and post-operative characteristics are shown in Table 2 . Of the 34 eyes, 33 (97.1%) were taking at least 1 glaucoma medication prior to surgery. The mean follow-up time was 6.1±4.8mo (median, 5.5mo; range, 1d to 16mo). Three eyes (8.8%) from 3 patients were seen at 1-day follow-up, then lost to further follow-up. At 1-month follow-up (n=31) and 6-month follow-up (n=17), the number of ocular hypotensive medications significantly decreased (P<0.001 and P=0.05, respectively). At 1-month (n=31), 6-month (n=17), and 1-year (n=12) follow-up, 20 patients (64.5%), 7 patients (41.2%), and 4 patients (33.3%) were able to discontinue all glaucoma medications, respectively.
The mean IOP decreased compared to baseline at 1-month, 6-month, and 1-year follow-up (P=0.99, 0.58 and 0.76, respectively), but the difference was not statistically significant (Table 2 ). There were 3 eyes (8. The iStent applicator is pressed along the landing strip; D: The iStent is released from the applicator and directly implanted into the TM. 
DISCUSSION
The purpose of the present study was to describe a novel technique of creating a landing strip to assist with iStent implantation. Our results showed that implantation using this technique significantly decreased the mean number of postoperative medications at 1-month and 6-month follow-up, consistent with findings from other studies [1, [4] [5] . At 1-year follow-up, there was a reduction in the number of hypotensive medications, although this result was no longer statistically significant, possibly due to the small sample size (n=12).
Over 60% of patients were able to discontinue all medications post-operatively at 1-month follow up. Since patients often experience challenges adhering to hypotensive medications [6] , reducing medications with stent implantation may help overcome these challenges. However, several studies have shown that the mean number of medications increases as follow-up time lengthens [4, 7] , which was seen in our study.
Although the mean number of medications increased as follow-up time increased, 33% of patients had appropriate IOP without any medications at 1-year follow-up.
Our study showed that there was a decrease in IOP at 1-month follow-up and this IOP-lowering effect continued at 6-month follow-up. Other studies have also found that there is a delay in IOP reduction, as IOP continues to decrease at 6-month followup [4, 8] . The mechanism of the iStent is to increase outflow of aqueous humor. The mean IOP at baseline in our study was 19.7±4.1 mm Hg, so reduction in IOP would theoretically be less in normotensive eyes compared to hypertensive eyes.
In addition, it is possible to place more than 1 iStent during cataract surgery. Several studies have shown that implanting multiple iStents resulted in sustained IOP reduction with significantly fewer medications after 12mo of follow-up [9] [10] .
There were 3 patients with elevated IOP on post-operative day 1, and 2 patients ultimately required trabeculectomy.
Stent failure in these patients may have occurred due to aqueous outflow obstruction past Schlemm's canal or postoperative TM dysfunction. Despite the possibility of failure, it is reasonable to consider iStent implantation to lower IOP since there are few adverse events or late-onset complications associated with the iStent [1] [2] .
In our study, the only intra-operative complication was hemorrhage seen in 1 eye, which supports the safety of iStent implantation seen in other studies [1] [2] . The most common postoperative complication was a hyphema. Previous studies found that hyphema was common after iStent implantation [7] [8] [9] , including a case series where hyphema was seen in 7 of 10 eyes [7] .
Our study is limited by the small sample size and short followup period. Further follow-up is needed to determine the longterm outcomes of this technique. In addition, previous studies have shown that there is a reduction in IOP and number of glaucoma medications from phacoemulsification alone [11] .
A major limitation of our study is the inability to discern the effect of phacoemulsification alone versus phacoemulsification with iStent implantation on reduction of IOP and number of glaucoma medications. Although several studies have shown that iStent may be more effective in reducing IOP and number of hypotensive medications than phacoemulsification alone [1] [2] , further research needs to be conducted. Another limitation is our study population mainly consisted of Caucasians and
patients with primary open angle glaucoma. As a result, it is difficult to extrapolate our results to other races and types of glaucoma. Additional research is needed to determine the outcomes of this technique in other populations. Despite these limitations, the landing strip technique appears to be an effective way to assist iStent implantation. 
